Jan 3, 2023

Evidence Based Dietary and Pharmacologic Approaches to Manage Patients with Hyperkalemia and Associated Comorbidities

EARNed Credits


AMA PRA Category 1 CreditTM


A 4-Part Hyperkalemia Modular CME Podcast Series 

Pre Quiz

Complete the pre-quiz poll to access the course episodes. 

Prequiz Podcast Evidence Based Dietary and Pharmacologic Approaches to Manage Patients with Hyperkalemia and Associated Comorbidities

Who Should Attend

Provided By

Course Faculty

George Bakris, MD
Professor of Medicine Director, AHA Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL
Deborah Clegg, PhD
Professor, Department of Internal Medicine Foster School of Medicine Vice President for Research Texas Tech University Health Sciences Center El Paso El Paso, TX
Pamela Kushner, MD
Clinical Professor of Family Medicine University of California Medical Center Orange, CA
Biff Palmer, MD
Professor of Internal Medicine Distinguished Teaching Professor University of Texas Southwestern Medical Center Dallas, TX
Matthew Weir, MD
Professor and Director Division of Nephrology University of Maryland School of Medicine Baltimore, MD

Available On

Additional Course Information

It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships relating to the topics of this educational activity. Any relevant financial relationships are mitigated via a content review by planning committee members and faculty with no relevant financial relationships.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

Faculty Relationship Identified With:
George Bakris, MD Consultant/Advisor: Alnylam; AstraZeneca; Bayer;
DiaMedica Therapeutics; InREGEN; Ionis; Janssen; KBP Biosciences; Novo Nordisk; Quantum Genomics
Deborah Clegg, PhD Nothing to disclose
Pamela Kushner, MD Consultant/Advisor: AstraZeneca; Abbot; Bayer; BI/Lily; Intuity; Janssen; GSK
Speaker’s Bureau: AstraZeneca; Bayer; BI/Lily; Janssen; GSK
Biff Palmer, MD Nothing to disclose
Matthew Weir, MD Consultant/Advisor: Akebia; AstraZeneca; Bayer; Boehringer Ingelheim; GSK; Janssen; Merck; Novo Nordisk; Vifor Pharma


Earn your Credits After Completing Podcast Episodes

Related Podcast Courses

Advances in Slowing the Progression of CKD with SGLT2 Inhibitors